2014-2026 Global Genetic Engineering Drug Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
SKU ID :Maia-14763312 | Published Date: 10-Dec-2019 | No. of pages: 130Description
The worldwide market for Genetic Engineering Drug is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2026, from X.X million US$ in 2019.
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in
Major Companies Covered
Anhui Anke Biotechnology (Group) Co., Ltd
GeneScience Pharmaceuticals Co., Ltd
Shenzhen Neptunus Interlong Bio-Technique Co., Ltd
Biotech Pharmaceutical Co., Ltd
Beijing SL Pharmaceutical Co., Ltd
3SBio Inc.
Shanghai Lansheng Guojian Pharmaceutical Co., Ltd
Tonghua Dongbao Pharmaceutical Co., Ltd
Jiangsu Sihuan Bioengineering Co., Ltd
Major Types Covered
Monoclonal Antibody
Recombinant Human Erythropoietin
Recombinant Human Interferon
Recombinant Human Growth Hormone
Recombinant Human Insulin
Major Applications Covered
<30 Years Old
30 Years Old-60 Years Old
>60 Years Old
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…
2019
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in
Major Region
s, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.Major Companies Covered
Anhui Anke Biotechnology (Group) Co., Ltd
GeneScience Pharmaceuticals Co., Ltd
Shenzhen Neptunus Interlong Bio-Technique Co., Ltd
Biotech Pharmaceutical Co., Ltd
Beijing SL Pharmaceutical Co., Ltd
3SBio Inc.
Shanghai Lansheng Guojian Pharmaceutical Co., Ltd
Tonghua Dongbao Pharmaceutical Co., Ltd
Jiangsu Sihuan Bioengineering Co., Ltd
Major Types Covered
Monoclonal Antibody
Recombinant Human Erythropoietin
Recombinant Human Interferon
Recombinant Human Growth Hormone
Recombinant Human Insulin
Major Applications Covered
<30 Years Old
30 Years Old-60 Years Old
>60 Years Old
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…
Years considered for this report:
Historical Years:
2014-2018Base Year:
2019Estimated Year:
2019Forecast Period:
2019-2026TOC
Tables & Figures
Companies
- PRICE
-
$3460$5000Buy Now